Global Oncology HEOR & Payer Evidence Generation, Senior Manager (m/f/x)

at  Daiichi Sankyo Europe

The Senior Manager, Global Health Economics Outcomes Research (HEOR) and Evidence Generation reports to the Senior Director Global HEOR asset leader and will work cross-functionally to implement HEOR and evidence generation projects. The person will work with other teams and senior leaders to support the clinical development and value creation of the company’s oncology asset. Responsibilities include the implementation of outcomes research strategies, health economics research planning, and process improvements to ensure patient access to Daiichi Sankyo’s products. This individual will ensure that rigorous HEOR analyses and studies are conducted to support the clinical and economic value proposition associated with the Daiichi Sankyo Oncology product/s. The work involves developing global cost effectiveness and budget impact models and to fill data gaps to support access needs in HTA markets, as well as to provide support related to the design and implementation of outcomes research & health economic studies that supports key publications, reimbursement strategies. The person will work closely with other members of the Global Market Access & Pricing department to develop RWE and support market access initiatives aligned to Daiichi Sankyo’s products, and represent the department in cross functional working groups and committees from time to time.

EDUCATION & PROFESSIONAL EXPERIENCE:

• Master’s or Bachelor’s degree in a relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology)
• Minimum 5 years’ experience in the healthcare or pharmaceutical industry working in the HEOR field
• Hands on experience with HEOR methodologies across all phases of the product life cycle is preferred
• Track record of successful application of HEOR & RWE with key external stakeholders in key HTA markets
• Knowledge and experience of Oncology therapy areas is strongly preferred
• Demonstrates understanding and (advanced) knowledge of key drug development processes, plans, studies, and strategies including clinical, regulatory, scientific, operational, and commercial aspects of drug development. Uses knowledge to the organization’s advantage; generates new ideas and enables the organization to improve business performance.
• Demonstrates understanding and (advanced) knowledge of HEOR methods and RWD, and the issues and challenges of applying these alongside clinical studies in drug development, and applies this knowledge to design HEOR strategies and RWE studies
• Demonstrates understanding of the commercial and market access policy environment across major markets and harnesses this knowledge to design effective HEOR evidence development strategies to support optimal market access for DS medicines
• Ability to influence and navigate in a matrix organization, with proven ability to work cross-functionally, build coalitions and develop strong partnerships across functions
• Demonstrates strategic thinking, team leadership, and ability to travel up to 30%
• Experience within a pharmaceutical industry, consulting, or equivalent organization involved in research and development of healthcare technologies and/or delivery solutions
• Outstanding writing and presentation skills and ability to work under pressure, to take accountability for business challenges, think strategically and tackle complex problems
• Intellectual curiosity and ability to identify trends and emerging patters in areas such as RWE, HEOR, HTA assessments, Market Access, and Healthcare delivery and payer requirements

The Global Oncology HEOR and RWE Senior Manager will have the responsibility and accountability for the following:

• Prepare global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products
• Conduct HEOR and RWE studies such as early economic models, burden of illness studies, external control arms to support single arm trials, and drive the development, analysis, and interpretation of patient-reported outcome (PRO) endpoints in clinical trials
• Conduct systematic literature reviews to build payer evidence, economic models, and Global Value Dossiers
• Oversee analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions
• Conduct RWE studies to support the value story for payers and reimbursement submissions
• Build global cost effectiveness and budget impact models for HTA submissions to support reimbursement of indications for Daiichi Sankyo’s oncology products
• Develop HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products
• Manage vendors in the conduct of HEOR and RWE projects
• Collaborate cross-functionally with and other internal stakeholders such as Medical Affairs, Clinical Development, Marketing, Biostats, etc